Search Results

You are looking at 1 - 3 of 3 items for

  • Author or Editor: Joyce A. M. Wootton x
  • Refine by Access: All Content x
Clear All Modify Search

Summary

Collagen type I was purified from equine skin and flexor tendon, and type II collagen was purified from equine articular cartilage. The proteoglycans in these tissues were extracted, using guanidine hcl; the collagens were solubilized, using pepsin digestion, then were selectively precipitated with NaCl. Gel electrophoresis indicated that the precipitates contained only type I or type II collagen. Amino acid analysis indicated that collagen constituted > 97% of the total protein in the precipitates. Hydroxylation of proline was 42.0 ± 0.6% (mean ± sem) in α1(I) and α2(I), and was 48.1 ± 1.3% in α1(ID chains. The hydroxylation of lysine was 23.2 ± 0.7% in α1(I) and 34.1 ± 0.9% in α2(D) chains from tendon, and 49.6 ± 4.3% in a1( chains from cartilage. The cyanogen bromide (CB)-peptide patterns of chromatographically purified equine α2(I) and α1(II) chains were similar to those published previously for rat, bovine, and human α2 and α1 chains. However, the CB-peptide pattern of the equine α1(I) chain resembled the guinea pig α1(I) chain, which has no methionine between CB7 and CB6. Purified equine α1(I)CB7,6 contained no methionine, methionine sulfoxide, or homoserine lactone. Mass of 42.26 kd was determined by use of mass spectrometry, and N-terminal sequence analysis established that the first 12 amino acids of this CB7,6 were identical to the sequence of human α1(I)CB7. Because of this species specific difference in structure of the α1(I) chain, equine CB-peptides should be used as standards in studies of variations in the proportions of type I and type II collagens in equine tissues expressing the phenotype of fibrous tissue and cartilage.

Free access
in American Journal of Veterinary Research

Abstract

Objective—To determine the gene sequences of canine and feline cardiac troponin I (cTnI), express the protein from the cloned gene in vitro, and validate the use of a commercial cTnI serum analyzer in these species via detection of the expressed protein or comparison of sequence homology.

Sample Population—Samples of ventricular myocardium from 5 healthy adult mixed-breed dogs and 5 healthy adult domestic shorthair cats.

Procedure—The RNA was extracted from myocardial samples, and cDNA was synthesized via reverse transcriptase polymerase chain reaction and sequenced. The canine cDNA for the coding region was expressed in cell culture and analyzed by western blot and sandwich enzyme-linked immunosorbent assays.

Results—Canine and feline cTnI genes were cloned and sequenced. Homology of the nucleotide and amino acid sequences of the canine and feline cTnI genes with human and rodent cTnI genes were high; the greatest homology was detected between canine and feline genes (95% and 96%, respectively). Recombinant canine cTnI protein was detected by a commercial serum cTnI analyzer and by western blot analysis.

Conclusions and Clinical Relevance—Results indicated that commercial cTnI analyzers can be used to measure serum cTnI concentration from dogs and cats. Additionally, our preliminary characterization of the feline cTnI gene may facilitate further investigation of cTnI and its role in familial hypertrophic cardiomyopathy in cats. ( Am J Vet Res 2004;65:53–58)

Full access
in American Journal of Veterinary Research